虚血性心疾患発症に及ぼす経口血糖降下剤の影響

DOI Web Site

書誌事項

タイトル別名
  • Effect of Oral Hypoglycemic Agents on Occurrence of Ischemic Heart Disease
  • キョケツセイ シンシッカン ハッショウ ニ オヨボス ケイコウ ケットウ コウカザイ ノ エイキョウ

この論文をさがす

抄録

ATP sensitivity potassium (KATP) channels exist in not only a pancreas β cell but also the cardiac muscle and the smooth muscle as well. The β cell, cardiac and smooth muscle types of KATP channels are involved in Insulin secretion, the cardiac muscle protection at myocardial ischemia and the vascular tone respectively. These sulfonylurea (SU) receptors exist as the subunits of the KATP channels and it is expected that the protection by the cardiac KATP channel and the tone regulation by the smooth muscle KATP channel decline at the closure by SU. Therefore SU receptor occupancy of the β cell, cardiac and smooth muscle was calculated by the pharmacokinetic parameters and the SU receptor affinity with the administration of the usual dose and compared variously with oral hypoglycemic agents to combine with SU receptors. The calculated SU receptor occupancy in the cardiac KATP channel by Glibenclamide and Glimepiride isn't very high. This result suggests that the effect of them on the cardiac muscle couldn't be denied completely.<br>Through investigating 110 diabetic cases to verify the effect of oral hypoglycemic agents occurrence of Ischemic Heart Disease (IHD), we found that the IHD group has more patients who have taken oral hypoglycemic agents compared to non-IHD group, however the difference was not very significant.

収録刊行物

  • 医療

    医療 61 (7), 458-465, 2007

    一般社団法人 国立医療学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ